Related Experiment Video
Updated: Aug 4, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
[Multisystemic severe infection with Chlamydia pneumoniae]
Nader Perroud1, Gregory Clark, Pierre Reusser
1Division de Médecine Hôpital régional, 2900 Porrentruy. pierre.reusser@cgh.ch
Abstract:
Chlamydia pneumoniae (CP) is responsible for 8-10% of community acquired pneumonia. However, multiorgan disease is rare and the association with a cutaneous vasculitis has only been described once. We report a case of serious systemic CP infection with capillary leak syndrome and cutaneus vasculitis who was treated successfully with levofloxacin.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
07:30Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Phylum Chlamydiae
Atypical Pneumonia
Pneumonia I: Introduction